Kaplan Andrew T. bought KLRA
April 20, 2026 · Form 4 insider transaction
Kaplan Andrew T. bought 8,398,438 shares of Kailera Therapeutics, Inc. at $16.00 per share, a transaction worth $134.38M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,398,438
Price
$16.00
Total value
$134.38M
InsiderKaplan Andrew T.
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateApril 20, 2026
Filing dateApril 20, 2026
Shares owned after26,255,581
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Represents securities held directly by BCPE Perseus Investor, LP ("BCPE Perseus").; Mr. Kaplan is a Partner of Bain Capital Investors, LLC ("BCI"). BCI is the ultimate general partner of BCPE Perseus. As a result, Mr. Kaplan may be deemed to share voting and dispositive power with respect to the securities held by BCPE Perseus. Mr. Kaplan disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.